Search
Filter by Topic
- Reproduction (89) Apply Reproduction filter
- People (64) Apply People filter
- Legal (55) Apply Legal filter
- Publications (43) Apply Publications filter
- Technologies (27) Apply Technologies filter
- Organizations (22) Apply Organizations filter
- Disorders (17) Apply Disorders filter
- Outreach (17) Apply Outreach filter
- Religion (17) Apply Religion filter
- Ethics (15) Apply Ethics filter
- Experiments (12) Apply Experiments filter
- Processes (8) Apply Processes filter
- Reproductive Health Arizona (7) Apply Reproductive Health Arizona filter
- Theories (7) Apply Theories filter
- Organisms (4) Apply Organisms filter
- RHAZ (4) Apply RHAZ filter
- Places (2) Apply Places filter
Post-Coital Oral Emergency Contraception
Post-coital oral emergency contraception is used for the prevention of pregnancy after intercourse. The contraception comes in the form of pills, often collectively referred to as morning-after pills. Post-coital use of morning-after pills separates them from traditional contraception which is either a continual preventative process, such as the birth control pill, or used during intercourse, such as condoms.
Format: Articles
Subject: Processes, Reproduction
The Birth Control Pill
The birth control pill, more commonly known as "the pill" is a form of contraception taken daily in pill form and consisting of synthetic hormones formulated to prevent ovulation, fertilization, and implantation of a fertilized egg. The US Food and Drug Administration (FDA) approved the first birth control pill, Enovid, in June 1960. It was the first contraceptive pill marketed worldwide. Since then a number of different pills have been developed, which differ in hormone type and dosage, and whether they contain one hormone (the minipill) or two (the combination pill).
Format: Articles
Subject: Technologies, Reproduction
Plan B: Emergency Contraceptive Pill
Plan B is a progestin-only emergency contraceptive pill (ECP) that can be taken within seventy-two hours of unprotected sex in order to prevent an unwanted pregnancy. Plan B was created in response to the United States Food and Drug Administration's (US FDA) 1997 request for new drug applications (NDAs) for a dedicated ECP product, and was approved for sales in the US in 1999. Duramed, a subsidiary of Barr Pharmaceuticals, manufactures Plan B for The Women's Capital Corporation (WCC), which owns the patent for Plan B.
Format: Articles
Subject: Technologies, Reproduction
“Explaining Recent Declines in Adolescent Pregnancy in the United States: The Contribution of Abstinence and Improved Contraceptive Use” (2007), by John S. Santelli, Laura Duberstein Lindberg, Lawrence B. Finer, and Susheela Singh
In “Explaining Recent Declines in Adolescent Pregnancy in the United States: The Contribution of Abstinence and Improved Contraceptive Use,” hereafter “Explaining Recent Declines,” researchers John S. Santelli, Laura Duberstein Lindberg, Lawrence B. Finer, and Susheela Singh discuss what led to the major decline in US adolescent pregnancy rates from 1995 to 2002. Working with the Guttmacher Institute, a reproductive health research organization, they found that the decline in US adolescent pregnancy rates between 1995 and 2002 was primarily due to improved contraceptive use.
Format: Articles
Subject: Publications, Reproduction
Enovid: The First Hormonal Birth Control Pill
Enovid was the first hormonal birth control pill. G. D. Searle and Company began marketing Enovid as a contraceptive in 1960. The technology was created by the joint efforts of many individuals and organizations, including Margaret Sanger, Katharine McCormick, Gregory Pincus, John Rock, Syntex, S.A. Laboratories, and G.D. Searle and Company Laboratories.
Format: Articles
Subject: Technologies, Reproduction
Min Chueh Chang (1908-1991)
As one of the researchers involved in the development of the oral contraceptive pill, Min Chueh Chang helped to revolutionize the birth control movement. Although best known for his involvement with "the pill," Chang also made a number of discoveries throughout his scientific career involving a range of topics within the field of reproductive biology. He published nearly 350 articles in scientific journals.
Format: Articles
Subject: People, Reproduction
John Charles Rock (1890-1984)
Born on 24 March 1890 in Marlborough, Massachusetts, to Ann and Frank Rock, John Charles Rock was both a devout Catholic and one of the leading investigators involved in the development of the first oral contraceptive pill. In 1925 he married Anna Thorndike, with whom he later had five children. He spent over thirty years of his career as a clinical professor of obstetrics at Harvard Medical School, and in 1964 the Center for Population Studies of the Harvard School of Public Health established the John Rock Professorship.
Format: Articles
Subject: People, Reproduction
Katharine McCormick (1876-1967)
Katharine Dexter McCormick, who contributed the majority of funding for the development of the oral contraceptive pill, was born to Josephine and Wirt Dexter on 27 August 1875 in Dexter, Michigan. After growing up in Chicago, Illinois, she attended the Massachusetts Institute of Technology (MIT), where she graduated in 1904 with a BS in biology. That same year, she married Stanley McCormick, the son of Cyrus McCormick, inventor and manufacturer of the mechanized reaper.
Format: Articles
Subject: People, Ethics, Reproduction
“Cardiovascular Risk Associated With the Use of an Etonogestrel-Containing Vaginal Ring” (2013), by Jürgen Dinger, Sabine Möhner, and Klaas Heinemann
In October 2013, Jürgen Dinger, Sabine Möhner, and Klaas Heinemann published the article “Cardiovascular Risk Associated With the Use of an Etonogestrel-Containing Vaginal Ring,” hereafter “Cardiovascular Risk,” in the journal Obstetrics and Gynecology. The authors enrolled patients in the study who were new users of either a vaginal contraceptive ring known as NuvaRing or a combined oral contraceptive pill. A combined oral contraceptive pill contains a formulation of the hormones progesterone and estrogen.
Format: Articles
Subject: Technologies, Reproduction
Thesis: Dismantling Legal Constraints to Contraception in the 1900s
In the late nineteenth century, the Comstock Act of 1873 made the distribution of contraception illegal and classified contraception as an obscenity. Reflecting the predominant attitude towards contraception at the time, the Comstock Act was the first federal anti-obscenity law that targeted contraception. However, social acceptance of birth control changed at the turn of the twentieth century. In this thesis, I analyzed legislation, advocates, and literature pertinent to that social change to report on the events leading up to the decriminalization of contraception.
Format: Essays and Theses
Subject: People, Legal, Reproduction
Oral Glucose Tolerance Test for Gestational Diabetes
In the twentieth century, researchers developed the oral glucose tolerance test, or OGTT, as a method to diagnose different types of diabetes, a medical condition that causes blood sugar levels to become abnormally high. During the test, a healthcare provider measures a person’s blood sugar levels before and after the person consumes a predetermined amount of glucose solution. While not exclusively used for pregnant women, an OGTT may test for gestational diabetes which, according to the International Diabetes Federation, affected one in six pregnancies worldwide in 2019.
Format: Articles
Subject: Technologies, Reproduction, Experiments
NuvaRing
The NuvaRing is a self-administered hormonal contraceptive device in the form of a flexible plastic ring that is inserted into the vagina. It releases the hormones etonogestrel and ethinylestradiol, which are synthetic forms of the female reproductive hormones progesterone and estrogen, respectively. The pharmaceutical company Organon first made NuvaRing in the Netherlands in 1980s. The Netherlands first approved it for use in February of 2001, and the United States did the same in October of that year.
Format: Articles
Subject: Technologies, Reproduction, Legal
Gregory Goodwin Pincus (1903-1967)
Gregory Goodwin Pincus, one of the original researchers responsible for the development of the first oral contraceptive pill, was born in Woodbine, New Jersey, on 19 April 1903 to Russian Jewish parents. In 1924 Pincus received his BS degree from Cornell University, and in 1927 he received his MS and PhD from Harvard University, having studied under William Ernest Castle and William John Crozier.
Format: Articles
Subject: People, Reproduction
Copper Intrauterine Device (IUD)
The copper intrauterine device, or IUD, is a long-term, reversible contraceptive first introduced by Howard Tatum and Jamie Zipper in 1967. Health care providers place an IUD inside a woman’s uterus to prevent pregnancy. Copper IUDs are typically made of T-shaped plastic with some portion covered with exposed copper. Prior to the invention of the first IUDs, women had few long-term options for safe and reliable birth control. Those options mostly consisted of barrier methods and the oral birth control pill, which were only effective if used correctly and consistently.
Format: Articles
Subject: Technologies
Progestin: Synthetic Progesterone
Progestin is a synthetic form of progesterone, a naturally occurring hormone, which plays an important role in the female reproductive cycle. During the 1950s two types of progestin that were later used in birth control pills were created, norethindrone and norethynodrel. In 1951 Carl Djerassi developed norethindrone at Syntex, S.A. laboratories located in Mexico City, receiving a patent on 1 May 1956. In 1953 Frank Colton developed norethynodrel at G.D. Searle and Company laboratories located in Chicago, receiving a patent on 29 November 1955.
Format: Articles
Subject: Technologies, Reproduction
The Time Has Come: A Catholic Doctor's Proposals to End the Battle over Birth Control (1963), by John Rock
In 1963, Roman Catholic fertility doctor John Rock published The Time Has Come: A Catholic Doctor's Proposals to End the Battle over Birth Control, a first-person treatise on the use of scientifically approved forms of birth control for Catholic couples. The first contraceptive pill, called Enovid, had been on the market since June 1960, and Rock was one of the leading researchers in its development. In The Time Has Come, Rock explicitly describes the arguments for and against the use of birth control from both a religious and a scientific perspective.
Format: Articles
Subject: Publications, Religion, Reproduction
Barbara Seaman (1935–2008)
Barbara Seaman was a writer, investigator, and advocate for female healthcare rights during the twentieth century in the United States. Seaman’s work addressed the gendered prejudice she observed in the US healthcare system and argued that women of the 1960s lacked the proper tools to make informed decisions about pregnancy care, breastfeeding, childbirth, and contraception. Seaman wrote the book The Doctor’s Case Against the Pill in 1969 to expose the dangers in prescribing and consuming high doses of estrogen in the form of birth control.
Format: Articles
Subject: People
The Dalkon Shield
The Dalkon Shield was an intrauterine contraceptive device (IUD) that women used in the early 1970s and 1980s. Produced by the A.H. Robins Company in the US, the Dalkon Shield was a contraceptive device placed directly into a woman’s uterus that was supposed to prevent the development of a fetus in the uterus. In the 1980s, researchers uncovered an array of severe birth defects and injuries caused by the Dalkon shield, including pelvic infection, infertility, and death of the user. Eventually the A.H.
Format: Articles
Subject: Technologies
"The Inductive Capacity of Oral Mesenchyme and Its Role in Tooth Development" (1969-1970), by Edward J. Kollar and Grace R. Baird
Between February 1969 and August 1970 Edward Kollar and Grace Baird, from the University of Chicago in Chicago, Illinois, published three papers that established the role of the mesenchyme in tooth induction. Drawing upon a history of using tissue interactions to understand differentiation, Kollar and Baird designed their experiments to understand how differentiated structures become specified. Their work overturned a widely accepted model that epithelium controls the identity of the structure, a phenomenon called structural specificity.
Format: Articles
Subject: Experiments
First American Birth Control Clinic (The Brownsville Clinic), 1916
On 16 October 1916, Margaret Sanger opened one of the first birth control clinics in the United States in Brooklyn, New York, which some have called the Brownsville Clinic. Located at 46 Amboy Street, the clinic was a place where Sanger and her staff verbally communicated with women seeking information about birth control. During the early 1900s, both birth control and abortion were illegal in the US, and publication or circulation of information on both topics was deemed obscene and illegal by the federal Comstock Act.
Format: Articles
Subject: Organizations
Estrogen and the Menstrual Cycle in Humans
Estrogen is the primary sex hormone in women and it functions during the reproductive menstrual cycle. Women have three major types of estrogen: estrone, estradiol, and estriol, which bind to and activate receptors within the body. Researchers discovered the three types of estrogen over a period of seven years, contributing to more detailed descriptions of the menstrual cycle. Each type of estrogen molecule contains a slightly different arrangement or number of atoms that in turn causes some of the estrogens to be more active than others.
Format: Articles
Subject: Theories, Reproduction
Hormone Releasing Intrauterine Devices
Hormone releasing intrauterine devices or hormonal IUDs are contraceptive devices placed in a woman’s uterus to prevent pregnancy by continuously releasing a low dose of certain hormones. Jouri Valter Tapani Luukkainen, a medical researcher at the University of Helsinki, introduced the first hormonal IUD in 1976. Luukkainen’s IUD was a plastic device shaped like a capital T.
Format: Articles
Subject: Technologies
The Development of Mifepristone for Use in Medication Abortions
In the 1980s, researchers at the pharmaceutical company Roussel-Uclaf in Paris, France, helped develop a biological compound called mifepristone. When a woman takes it, mifepristone interferes with the function of hormones involved in pregnancy and it can therefore be used to terminate pregnancies. In 2000, the US Food and Drug Administration approved mifepristone, also called RU 486, as part of a treatment to induce abortions using drugs instead of surgery, a method called medication abortion.
Format: Articles
Subject: Reproduction
Margaret Higgins Sanger (1879-1966)
Margaret Higgins Sanger advocated for birth control in the United States and Europe during the late nineteenth and early twentieth centuries. Although people used contraceptives prior to the twentieth century, in the US the 1873 Comstock Act made the distribution of information relating to the use of contraceptives illegal, and similar state-level Comstock laws also classified discussion and dissemination of contraceptives as illegal.
Format: Articles
Subject: People, Reproductive Health Arizona, Reproduction, Outreach
Evangelium Vitae (1995), by Pope John Paul II
The encyclical entitled "Evangelium Vitae," meaning "The Gospel of Life," was promulgated on 25 March 1995 by Pope John Paul II in Rome, Italy. The document was written to reiterate the view of the Roman Catholic Church on the value of life and to warn against violating the sanctity of life. The document focuses on right to life issues including abortion, birth control, and euthanasia, but also touches on other concepts relevant to embryology, such as contraception, in vitro fertilization, sterilization, embryonic stem cell research, and fetal experimentation.
Format: Articles
Subject: Religion, Reproduction